Smartleaf Asset Management LLC Acadia Pharmaceuticals Inc Transaction History
Smartleaf Asset Management LLC
- $1.13 Trillion
- Q2 2025
A detailed history of Smartleaf Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 827 shares of ACAD stock, worth $17,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
827
Previous 548
50.91%
Holding current value
$17,623
Previous $9.35 Million
95.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACAD
# of Institutions
345Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$914 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$325 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$257 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$192 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$132 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.45B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...